Equities

Kobayashi Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Kobayashi Pharmaceutical Co Ltd

Actions
  • Price (EUR)30.00
  • Today's Change-0.600 / -1.96%
  • Shares traded--
  • 1 Year change-12.28%
  • Beta0.1053
Data delayed at least 15 minutes, as of Mar 02 2026 07:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade Kobayashi Pharmaceutical Co Ltd (KOY:FRA) traded at 30.00, 9.49% above its 52-week low of 27.40, set on Dec 22, 2025.
52-week range
Today
27.40Dec 22 202535.40Mar 20 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open30.00
High30.00
Low30.00
Bid30.40
Offer32.40
Previous close30.60
Average volume0.00
Shares outstanding78.05m
Free float54.03m
P/E (TTM)118.54
Market cap455.03bn JPY
EPS (TTM)49.18
JPY
Annual div (ADY)0.5658
EUR
Annual div yield (ADY)1.85%
Div ex-dateDec 29 2025
Div pay-dateMar 09 2026
Next div ex-dateJun 29 2026
Next div pay-dateSep 01 2026
Data delayed at least 15 minutes, as of Mar 02 2026 07:11 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.